Table 2.
Respondents involve PPP (n=116) | Respondents do not involve PPP or are not sure (n=71) | |
TDF domain: knowledge | ||
How familiar are you with involving PPP in numerical aspects of trials? | 4 (3.0–5.0), 116 | 2 (1.0–3.0), 71 |
TDF domain: skills | ||
Grade your own ability to involve PPP in numerical aspects of trials. | 4 (3.0–5.0), 116 | 2 (1.0–4.0), 71 |
PPP skills | ||
Do you think the PPP need to have particular experience or skills to be involved in numerical aspects of trials? | ||
Yes | 52 (44.8) | 41 (57.7) |
No | 64 (55.2) | 30 (42.3) |
TDF domain: social/professional role | ||
Is involving PPP in numerical aspects of trials an expected role within your job? | 46 (39.7) | 3 (4.2) |
TDF domain: beliefs about capability | ||
Do you feel confident in your ability to involve PPP in numerical aspects of trials? | 4 (3.0–5.0), 111 | 3 (2.0–4.0), 62 |
Do you think that involving PPP in numerical aspects of trials is hard to deliver? | 52 (44.8) | 34 (47.9) |
TDF domain: beliefs about consequences | ||
There is a good balance between the challenges of involving PPP in numerical aspects of trials and the potential benefits. | 68 (58.6) | 22 (31.0) |
TDF domain: reinforcement | ||
You get recognition from PPP when you involve them in numerical aspects of trials. | 35 (30.2) | 12 (16.9) |
You get recognition from work peers. | 21 (18.1) | 5 (7.0) |
You get recognition from your manager. | 23 (19.8) | 6 (8.5) |
TDF domain: environmental context and resources | ||
Have the resources needed to involve PPP in numerical aspects of trials. | 55 (47.4) | 16 (22.5) |
Employer provides support to involve PPP in numerical aspects of trials. | 47 (40.5) | 13 (18.3) |
Employer provides training to involve PPP in numerical aspects of trials. | 31 (26.7) | 7 (9.9) |
Involving PPP in numerical aspects of trials is compatible with daily practice. | 63 (54.3) | 17 (23.9) |
PPPs are motivated to get involved in numerical aspects of trials. | 59 (50.9) | 14 (19.7) |
TDF domain: social influences | ||
Most people who are important think I should involve PPP in numerical aspects of trials. | 5 (4.0–6.0), 94 | 3 (1.0–4.0), 50 |
Who encourages you to involve PPP in numerical aspects? | ||
No encouragement. | 7 (6.0) | 14 (19.7) |
Who is a barrier for you to involve PPP in numerical aspects? | ||
No barrier. | 47 (40.5) | 13 (18.3) |
TDF domain: behavioural regulation | ||
Do you have a clear plan on… | ||
Which numerical aspects of trials you should involve PPP with? | 33 (28.4) | 5 (7.0) |
How you will involve PPP in numerical aspects of trials? | 36 (31.0) | 6 (8.5) |
How often will you involve PPP in numerical aspects of trials? | 37 (31.9) | 4 (5.6) |
Data shown as median (25th–75th percentile) and count for scale variables, or n (%) out of N for binary variables.
PPP, patient and public partner; TDF, Theoretical Domains Framework.